These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 28048940)

  • 61. Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks.
    Lundsten S; Hernández VA; Gedda L; Sarén T; Brown CJ; Lane DP; Edwards K; Nestor M
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32325827
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stereoisomerism of stapled peptide inhibitors of the p53-Mdm2 interaction: an assessment of synthetic strategies and activity profiles.
    Yuen TY; Brown CJ; Xue Y; Tan YS; Ferrer Gago FJ; Lee XE; Neo JY; Thean D; Kaan HYK; Partridge AW; Verma CS; Lane DP; Johannes CW
    Chem Sci; 2019 Jul; 10(26):6457-6466. PubMed ID: 31316744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Applications of water molecules for analysis of macromolecule properties.
    Mitusińska K; Raczyńska A; Bzówka M; Bagrowska W; Góra A
    Comput Struct Biotechnol J; 2020; 18():355-365. PubMed ID: 32123557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.
    Chang YS; Graves B; Guerlavais V; Tovar C; Packman K; To KH; Olson KA; Kesavan K; Gangurde P; Mukherjee A; Baker T; Darlak K; Elkin C; Filipovic Z; Qureshi FZ; Cai H; Berry P; Feyfant E; Shi XE; Horstick J; Annis DA; Manning AM; Fotouhi N; Nash H; Vassilev LT; Sawyer TK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):E3445-54. PubMed ID: 23946421
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99.
    Lee XA; Verma C; Sim AYL
    Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors.
    Kannan S; Partridge AW; Lane DP; Verma CS
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
    Lemos A; Leão M; Soares J; Palmeira A; Pinto M; Saraiva L; Sousa ME
    Med Res Rev; 2016 Sep; 36(5):789-844. PubMed ID: 27302609
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toward Understanding the Molecular Recognition of Albumin by p53-Activating Stapled Peptide ATSP-7041.
    Tiwari G; Verma CS
    J Phys Chem B; 2017 Feb; 121(4):657-670. PubMed ID: 28048940
    [TBL] [Abstract][Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.